These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9872176)

  • 1. Reversal of the anticoagulant effects of warfarin by vitamin K1.
    Hirsh J
    Chest; 1998 Dec; 114(6):1505-8. PubMed ID: 9872176
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective evaluation of anticoagulant reversal with oral vitamin K1 while continuing warfarin therapy unchanged.
    Wentzien TH; O'Reilly RA; Kearns PJ
    Chest; 1998 Dec; 114(6):1546-50. PubMed ID: 9872186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seaweed, vitamin K, and warfarin.
    Bartle WR; Madorin P; Ferland G
    Am J Health Syst Pharm; 2001 Dec; 58(23):2300. PubMed ID: 11763808
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa.
    Barton CA; Johnson NB; Case J; Warden B; Hughes D; Zimmerman J; Roberti G; McMillian WD; Schreiber M
    Am J Emerg Med; 2015 Nov; 33(11):1562-6. PubMed ID: 26143317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired warfarin response secondary to high-dose vitamin K1 for rapid anticoagulation reversal: case series and literature review.
    Fugate SE; Nichols CM; Cudd LA
    Pharmacotherapy; 2004 Sep; 24(9):1213-20. PubMed ID: 15460182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticipating drug response. A commonly used anticoalgulant has many drug-drug interactions.
    Lilley LL; Guanci R
    Am J Nurs; 1998 Sep; 98(9):12. PubMed ID: 9739740
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of vitamin K on anticoagulant therapy depends on vitamin K status and the source and chemical forms of vitamin K.
    Johnson MA
    Nutr Rev; 2005 Mar; 63(3):91-7. PubMed ID: 15825811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin Poisoning with Delayed Rebound Toxicity.
    Berling I; Mostafa A; Grice JE; Roberts MS; Isbister GK
    J Emerg Med; 2017 Feb; 52(2):194-196. PubMed ID: 27838137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenge of regulating anticoagulant drugs: focus on warfarin.
    Mann KG
    Am Heart J; 2005 Jan; 149(1 Suppl):S36-42. PubMed ID: 15644792
    [No Abstract]   [Full Text] [Related]  

  • 10. Higher vitamin K intake is associated with better INR control and a decreased need for INR tests in long-term warfarin therapy.
    Leblanc C; Presse N; Lalonde G; Dumas S; Ferland G
    Thromb Res; 2014 Jul; 134(1):210-2. PubMed ID: 24824293
    [No Abstract]   [Full Text] [Related]  

  • 11. Warfarin resistance associated with parenteral nutrition.
    Cheung LK; Agi R; Hyman DJ
    Am J Med Sci; 2012 Mar; 343(3):255-8. PubMed ID: 22143126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin K in anticoagulation therapy.
    Hanslik T; Viboud C; Chadenat ML; Jubault V; Prinseau J
    Lancet; 2001 Feb; 357(9256):637; author reply 638. PubMed ID: 11558516
    [No Abstract]   [Full Text] [Related]  

  • 13. Change in International Normalized Ratio Among Patients Treated With Dicloxacillin and Vitamin K Antagonists.
    Pottegård A; Henriksen DP; Madsen KG; Hellfritzsch M; Damkier P; Stage TB
    JAMA; 2015 Jul; 314(3):296-7. PubMed ID: 26197191
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitamin K in anticoagulation therapy.
    Nash G
    Lancet; 2001 Feb; 357(9256):638. PubMed ID: 11558517
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin.
    Crowther MA; Ageno W; Schnurr T; Manfredi E; Kinnon K; Garcia D; Douketis JD
    Haematologica; 2005 Jan; 90(1):137-9. PubMed ID: 15642685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achievement of therapeutic international normalized ratio following adjustment of tube feeds.
    Krajewski KC; Butterfoss K
    J Clin Pharmacol; 2011 Mar; 51(3):440-3. PubMed ID: 20538908
    [No Abstract]   [Full Text] [Related]  

  • 17. Elevated international normalized ratio from vitamin K supplement discontinuation.
    Miesner AR; Sullivan TS
    Ann Pharmacother; 2011 Jan; 45(1):e2. PubMed ID: 21205949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary vitamin K intake and anticoagulation control during the initiation phase of warfarin therapy: a prospective cohort study.
    Li RC; Finkelman BS; Chen J; Booth SL; Bershaw L; Brensinger C; Kimmel SE
    Thromb Haemost; 2013 Jul; 110(1):195-6. PubMed ID: 23572189
    [No Abstract]   [Full Text] [Related]  

  • 19. The evolution of oral anticoagulant therapy.
    Dittus C; Ansell J
    Prim Care; 2013 Mar; 40(1):109-34. PubMed ID: 23402464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of INR reversal using fresh-frozen plasma in warfarin-associated intracerebral hemorrhage.
    Akhter M; Morotti A; Cohen AS; Chang Y; Ayres AM; Schwab K; Viswanathan A; Gurol ME; Anderson CD; Greenberg SM; Rosand J; Goldstein JN
    Intern Emerg Med; 2018 Jun; 13(4):557-565. PubMed ID: 28573379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.